Organon & Co | OGN - Ebit





Ebit Veränderung Datum
Bristol-Myers Squibb USD 3.56B 90M 2026-03
Celltrion KRW 13.41B 1.33B 2026-03
Cspc Pharmaceutical CNY 206.26M 1.02B 2025-12
Deva Holding AS TRY 820.88M 192.13M 2023-09
Dianthus Therapeutics USD -46.53M 23.01M 2026-03
Divis Laboratories Ltd INR 8.14B 420M 2026-03
Gilead Sciences USD 2.68B 284M 2026-03
Glaxosmithkline GBP 2.31B 14.92M 2026-03
Kangmei Pharma CNY -12.72M 13.97M 2026-03
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Laboratorios Farma EUR 135.05M 49.84M 2023-12
Malin Corporation EUR -1.1M 300K 2024-12
Medical Developments International AUD -36K 12.96M 2025-12
Merck USD -1.88B 8.12B 2026-03
Neuren Pharmaceuticals AUD 17.01M 154.09M 2025-12
Novartis USD 4.18B 118M 2026-03
Organigram Holdings CAD -9.79M 10.33M 2026-03
Organon & Co USD 324M 351M 2026-03
Ovoca Bio EUR -1.16M 4.48M 2025-06
Pharma Mar EUR 622K 42.99M 2026-03
Qiagen NV USD 121.88M 19.18M 2025-12
Sartorius EUR 160.7M 94.1M 2026-03
Sino Biopharmaceutical CNY 5.18B 3.32B 2025-06
Tilray USD -20.01M 9.34M 2025-09
Zealand Pharma A/S -707.05M 245.73M 2025-12